FibroGen
FGEN
FGEN
201 hedge funds and large institutions have $2.62B invested in FibroGen in 2018 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 73 increasing their positions, 44 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.02% more ownership
Funds ownership: 2.65% → 2.67% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
23% less capital invested
Capital invested by funds: $3.39B → $2.62B (-$777M)
Holders
201
Holding in Top 10
4
Calls
$61.7M
Puts
$31M
Top Buyers
| 1 | +$36.1M | |
| 2 | +$28.1M | |
| 3 | +$23.9M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$15.5M |
| 5 |
Bank of New York Mellon
New York
|
+$11.9M |
Top Sellers
| 1 | -$163M | |
| 2 | -$29.9M | |
| 3 | -$22.8M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$19.2M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$16.5M |